학술논문

Montelukast is a dual-purpose inhibitor of SARS-CoV-2 infection and virus-induced IL-6 expression identified by structure-based drug repurposing
Document Type
Article
Source
In: Computational and Structural Biotechnology Journal. (Computational and Structural Biotechnology Journal, January 2022, 20:799-811)
Subject
Language
English
ISSN
20010370